Table of Content

1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17

2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 25
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 27
2.2 Major Growth Drivers 31
2.3 Market Restraints and Challenges 37
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter’s Fiver Forces Analysis 44

3 Segmentation of Europe Market by Vaccine Type 48
3.1 Market Overview by Vaccine Type 48
3.2 Live/Attenuated Vaccines 50
3.3 Inactivated Vaccines 51
3.4 Subunit Vaccines 52
3.5 Toxoid Vaccines 53
3.6 Conjugate Vaccines 54
3.7 mRNA Vaccines 55
3.8 Recombinant Vector Vaccines 56
3.9 Other Vaccines 57

4 Segmentation of Europe Market by Disease 58
4.1 Market Overview by Disease 58
4.2 Pneumococcal Disease 60
4.3 Poliovirus 61
4.4 Hepatitis 62
4.5 Influenza 63
4.6 Measles, Mumps, and Rubella (MMR) 64
4.7 Varicella 65
4.8 Human Papilloma Virus 66
4.9 COVID-19 67
4.10 Other Diseases 68

5 Segmentation of Europe Market by Administration 69
5.1 Market Overview by Administration 69
5.2 Intramuscular Route 71
5.3 Subcutaneous Route 72
5.4 Oral Route 73
5.5 Intravenous Injection 74
5.6 Other Administration Routes 75

6 Segmentation of Europe Market by Patient 76
6.1 Market Overview by Patient 76
6.2 Pediatric Vaccines 78
6.3 Adult Vaccines 80

7 European Market 2022-2032 by Country 82
7.1 Overview of European Market 82
7.2 Germany 85
7.3 U.K. 88
7.4 France 91
7.5 Spain 94
7.6 Italy 97
7.7 Russia 100
7.8 Rest of European Market 103

8 Competitive Landscape 105
8.1 Overview of Key Vendors 105
8.2 New Product Launch, Partnership, Investment, and M&A 108
8.3 Company Profiles 109
AstraZeneca plc 109
Bavarian Nordic A/S 111
China National Biotec Group Company Ltd. 114
CSL Ltd. 116
Daiichi Sankyo Co. Ltd 118
Emergent BioSolutions Inc. 120
GlaxoSmithKline plc 122
Johnson & Johnson 126
Merck & Co. 128
Moderna Inc. 130
Novavax, Inc. 131
Pfizer Inc. 133
Sanofi SA 137
Takeda Pharmaceutical Co. Ltd. 140
RELATED REPORTS 142



List of Figures

List of Figures:

Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 17
Figure 4. Europe Preventive Vaccines Market, 2022-2032, $ mn 20
Figure 5. Development Stages of Preventive Vaccines 21
Figure 6. Impact of COVID-19 on Business 25
Figure 7. Primary Drivers and Impact Factors of Europe Preventive Vaccines Market 31
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million 34
Figure 9. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million 35
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 35
Figure 11. Primary Restraints and Impact Factors of Europe Preventive Vaccines Market 37
Figure 12. Investment Opportunity Analysis 41
Figure 13. Porter’s Fiver Forces Analysis of Europe Preventive Vaccines Market 44
Figure 14. Breakdown of Europe Preventive Vaccines Market by Vaccine Type, 2022-2032, % of Revenue 49
Figure 15. Europe Addressable Market Cap in 2023-2032 by Vaccine Type, Value ($ mn) and Share (%) 49
Figure 16. Europe Preventive Vaccines Market by Vaccine Type: Live/Attenuated Vaccines, 2022-2032, $ mn 50
Figure 17. Europe Preventive Vaccines Market by Vaccine Type: Inactivated Vaccines, 2022-2032, $ mn 51
Figure 18. Europe Preventive Vaccines Market by Vaccine Type: Subunit Vaccines, 2022-2032, $ mn 52
Figure 19. Europe Preventive Vaccines Market by Vaccine Type: Toxoid Vaccines, 2022-2032, $ mn 53
Figure 20. Europe Preventive Vaccines Market by Vaccine Type: Conjugate Vaccines, 2022-2032, $ mn 54
Figure 21. Europe Preventive Vaccines Market by Vaccine Type: mRNA Vaccines, 2022-2032, $ mn 55
Figure 22. Europe Preventive Vaccines Market by Vaccine Type: Recombinant Vector Vaccines, 2022-2032, $ mn 56
Figure 23. Europe Preventive Vaccines Market by Vaccine Type: Other Vaccines, 2022-2032, $ mn 57
Figure 24. Breakdown of Europe Preventive Vaccines Market by Disease, 2022-2032, % of Sales Revenue 59
Figure 25. Europe Addressable Market Cap in 2023-2032 by Disease, Value ($ mn) and Share (%) 59
Figure 26. Europe Preventive Vaccines Market by Disease: Pneumococcal Disease, 2022-2032, $ mn 60
Figure 27. Europe Preventive Vaccines Market by Disease: Poliovirus, 2022-2032, $ mn 61
Figure 28. Europe Preventive Vaccines Market by Disease: Hepatitis, 2022-2032, $ mn 62
Figure 29. Europe Preventive Vaccines Market by Disease: Influenza, 2022-2032, $ mn 63
Figure 30. Europe Preventive Vaccines Market by Disease: Measles, Mumps, and Rubella (MMR), 2022-2032, $ mn 64
Figure 31. Europe Preventive Vaccines Market by Disease: Varicella, 2022-2032, $ mn 65
Figure 32. Europe Preventive Vaccines Market by Disease: Human Papilloma Virus, 2022-2032, $ mn 66
Figure 33. Europe Preventive Vaccines Market by Disease: COVID-19, 2022-2032, $ mn 67
Figure 34. Europe Preventive Vaccines Market by Disease: Other Diseases, 2022-2032, $ mn 68
Figure 35. Breakdown of Europe Preventive Vaccines Market by Administration, 2022-2032, % of Sales Revenue 70
Figure 36. Europe Addressable Market Cap in 2023-2032 by Administration, Value ($ mn) and Share (%) 70
Figure 37. Europe Preventive Vaccines Market by Administration: Intramuscular Route, 2022-2032, $ mn 71
Figure 38. Europe Preventive Vaccines Market by Administration: Subcutaneous Route, 2022-2032, $ mn 72
Figure 39. Europe Preventive Vaccines Market by Administration: Oral Route, 2022-2032, $ mn 73
Figure 40. Europe Preventive Vaccines Market by Administration: Intravenous Injection, 2022-2032, $ mn 74
Figure 41. Europe Preventive Vaccines Market by Administration: Other Administration Routes, 2022-2032, $ mn 75
Figure 42. Breakdown of Europe Preventive Vaccines Market by Patient, 2022-2032, % of Revenue 77
Figure 43. Europe Addressable Market Cap in 2023-2032 by Patient, Value ($ mn) and Share (%) 77
Figure 44. Europe Preventive Vaccines Market by Patient: Pediatric Vaccines, 2022-2032, $ mn 78
Figure 45. Europe Preventive Vaccines Market by Patient: Adult Vaccines, 2022-2032, $ mn 80
Figure 46. Breakdown of European Preventive Vaccines Market by Country, 2022 and 2032, % of Revenue 83
Figure 47. Contribution to Europe 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 84
Figure 48. Preventive Vaccines Market in Germany, 2022-2032, $ mn 85
Figure 49. Preventive Vaccines Market in U.K., 2022-2032, $ mn 88
Figure 50. Preventive Vaccines Market in France, 2022-2032, $ mn 91
Figure 51. Preventive Vaccines Market in Spain, 2022-2032, $ mn 94
Figure 52. Preventive Vaccines Market in Italy, 2022-2032, $ mn 97
Figure 53. Preventive Vaccines Market in Russia, 2022-2032, $ mn 100
Figure 54. Preventive Vaccines Market in Rest of Europe, 2022-2032, $ mn 103
Figure 55. Growth Stage of Europe Preventive Vaccines Industry over the Forecast Period 105

List of Tables

List of Tables:

Table 1. Snapshot of Europe Preventive Vaccines Market in Balanced Perspective, 2022-2032 18
Table 2. World Economic Outlook, 2021-2031 23
Table 3. World Economic Outlook, 2021-2023 24
Table 4. Scenarios for Economic Impact of Ukraine Crisis 28
Table 5. World Health Spending by Region, $ bn, 2013-2020 36
Table 6. Main Product Trends and Market Opportunities in Europe Preventive Vaccines Market 40
Table 7. Europe Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 48
Table 8. Europe Preventive Vaccines Market by Disease, 2022-2032, $ mn 58
Table 9. Europe Preventive Vaccines Market by Administration, 2022-2032, $ mn 69
Table 10. Europe Preventive Vaccines Market by Patient, 2022-2032, $ mn 76
Table 11. Europe Preventive Vaccines Market: Pediatric Vaccines by Disease, 2022-2032, $ mn 79
Table 12. Europe Preventive Vaccines Market: Adult Vaccines by Disease, 2022-2032, $ mn 81
Table 13. Europe Preventive Vaccines Market by Country, 2022-2032, $ mn 84
Table 14. Germany Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 86
Table 15. Germany Preventive Vaccines Market by Disease, 2022-2032, $ mn 86
Table 16. Germany Preventive Vaccines Market by Administration, 2022-2032, $ mn 87
Table 17. U.K. Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 89
Table 18. U.K. Preventive Vaccines Market by Disease, 2022-2032, $ mn 89
Table 19. U.K. Preventive Vaccines Market by Administration, 2022-2032, $ mn 90
Table 20. France Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 92
Table 21. France Preventive Vaccines Market by Disease, 2022-2032, $ mn 92
Table 22. France Preventive Vaccines Market by Administration, 2022-2032, $ mn 93
Table 23. Spain Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 95
Table 24. Spain Preventive Vaccines Market by Disease, 2022-2032, $ mn 95
Table 25. Spain Preventive Vaccines Market by Administration, 2022-2032, $ mn 96
Table 26. Italy Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 98
Table 27. Italy Preventive Vaccines Market by Disease, 2022-2032, $ mn 98
Table 28. Italy Preventive Vaccines Market by Administration, 2022-2032, $ mn 99
Table 29. Russia Preventive Vaccines Market by Vaccine Type, 2022-2032, $ mn 101
Table 30. Russia Preventive Vaccines Market by Disease, 2022-2032, $ mn 101
Table 31. Russia Preventive Vaccines Market by Administration, 2022-2032, $ mn 102
Table 32. Preventive Vaccines Market in Rest of Europe by Country, 2022-2032, $ mn 104
Table 33. AstraZeneca plc: Company Snapshot 109
Table 34. AstraZeneca plc: Business Segmentation 110
Table 35. AstraZeneca plc: Product Portfolio 110
Table 36. Bavarian Nordic A/S: Company Snapshot 111
Table 37. Bavarian Nordic A/S: Marketed Products and Pipeline, as of July 2020 112
Table 38. China National Biotec Group Company Ltd.: Company Snapshot 114
Table 39. CSL Ltd.: Company Snapshot 116
Table 40. Daiichi Sankyo Co. Ltd.: Company Snapshot 118
Table 41. Emergent BioSolutions Inc.: Company Snapshot 120
Table 42. GlaxoSmithKline: Company Snapshot 122
Table 43. GlaxoSmithKline: Business Segmentation 123
Table 44. GlaxoSmithKline: Product Portfolio 124
Table 45. GlaxoSmithKline: Revenue, 2018-2020, $ bn 125
Table 46. GlaxoSmithKline: Recent Developments 125
Table 47. Johnson & Johnson: Company Snapshot 126
Table 48. Johnson & Johnson: Business Segments 127
Table 49. Merck & Co., Inc.: Company Snapshot 128
Table 50. Merck & Co., Inc.: Business Segmentation 128
Table 51. Merck & Co., Inc.: Revenue, 2018-2020, $ bn 129
Table 52. Moderna Inc.: Company Snapshot 130
Table 53. Novavax, Inc.: Company Snapshot 131
Table 54. Pfizer Inc.: Company Snapshot 133
Table 55. Pfizer Inc.: Business Segmentation 134
Table 56. Pfizer Inc.: Product Portfolio 135
Table 57. Pfizer Inc.: Revenue, 2018-2020, $ bn 136
Table 58. Pfizer Inc.: Recent Developments 136
Table 59. Sanofi: Company Snapshot 137
Table 60. Sanofi: Business Segmentation 137
Table 61. Sanofi: Revenue, 2018-2020, $ bn 139
Table 62. Takeda Pharmaceutical Co. Ltd.: Company Snapshot 140